191 related articles for article (PubMed ID: 16115294)
1. Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects.
Konno T; Shimizu M; Ino H; Fujino N; Hayashi K; Uchiyama K; Kaneda T; Inoue M; Masuda E; Mabuchi H
J Intern Med; 2005 Sep; 258(3):216-24. PubMed ID: 16115294
[TBL] [Abstract][Full Text] [Related]
2. Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population.
Konno T; Shimizu M; Ino H; Fujino N; Hayashi K; Uchiyama K; Kaneda T; Inoue M; Fujita T; Masuta E; Funada A; Mabuchi H
Am J Cardiol; 2005 Nov; 96(9):1308-12. PubMed ID: 16253604
[TBL] [Abstract][Full Text] [Related]
3. Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis.
Konno T; Fujino N; Hayashi K; Uchiyama K; Masuta E; Katoh H; Sakamoto Y; Tsubokawa T; Ino H; Yamagishi M
Clin Sci (Lond); 2007 Jun; 112(11):577-82. PubMed ID: 17263690
[TBL] [Abstract][Full Text] [Related]
4. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
[TBL] [Abstract][Full Text] [Related]
5. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J
Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640
[TBL] [Abstract][Full Text] [Related]
6. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
[TBL] [Abstract][Full Text] [Related]
7. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
Germans T; Wilde AA; Dijkmans PA; Chai W; Kamp O; Pinto YM; van Rossum AC
J Am Coll Cardiol; 2006 Dec; 48(12):2518-23. PubMed ID: 17174192
[TBL] [Abstract][Full Text] [Related]
8. Familial and sporadic hypertrophic myopathy: differences and similarities in a genotyped population. A long follow-up study.
Brito D; Richard P; Komajda M; Madeira H
Rev Port Cardiol; 2008 Feb; 27(2):147-73. PubMed ID: 18488914
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
10. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
[TBL] [Abstract][Full Text] [Related]
11. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathy.
Forissier JF; Charron P; Tezenas du Montcel S; Hagège A; Isnard R; Carrier L; Richard P; Desnos M; Bouhour JB; Schwartz K; Komajda M; Dubourg O
Eur Heart J; 2005 Sep; 26(18):1882-6. PubMed ID: 15860513
[TBL] [Abstract][Full Text] [Related]
14. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
[TBL] [Abstract][Full Text] [Related]
15. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.
Michels M; Soliman OI; Kofflard MJ; Hoedemaekers YM; Dooijes D; Majoor-Krakauer D; ten Cate FJ
JACC Cardiovasc Imaging; 2009 Jan; 2(1):58-64. PubMed ID: 19356534
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A
Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
[TBL] [Abstract][Full Text] [Related]
17. Novel electrocardiographic features in carriers of hypertrophic cardiomyopathy causing sarcomeric mutations.
Jalanko M; Heliö T; Mustonen P; Kokkonen J; Huhtala H; Laine M; Jääskeläinen P; Tarkiainen M; Lauerma K; Sipola P; Laakso M; Kuusisto J; Nikus K
J Electrocardiol; 2018; 51(6):983-989. PubMed ID: 30497761
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic cardiomyopathy in myosin-binding protein C (
Adalsteinsdottir B; Burke M; Maron BJ; Danielsen R; Lopez B; Diez J; Jarolim P; Seidman J; Seidman CE; Ho CY; Gunnarsson GT
Open Heart; 2020; 7(1):e001220. PubMed ID: 32341788
[TBL] [Abstract][Full Text] [Related]
19. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]